FDA approves first immunotherapy regimen for breast cancer

The US Food and Drug Administration has granted its first approval to an immunotherapy regimen for breast cancer, the agency announced Friday. (CNN Photo)

The US Food and Drug Administration has granted its first approval to an immunotherapy regimen for breast cancer, the agency announced Friday.

Posted: Mar 9, 2019 10:17 AM

(CNN) -- The US Food and Drug Administration has granted its first approval to an immunotherapy regimen for breast cancer, the agency announced Friday.

The treatment received accelerated approval for triple-negative breast cancer that is locally advanced or metastatic, that cannot be surgically removed and whose cells include a protein called PD-L1. It comprises a combination of immunotherapy and chemotherapy: Tecentriq and Abraxane, respectively.

The FDA's decision comes after an October study published in the New England Journal of Medicine found that the therapy extended progression-free survival -- the amount of time in which a patient's cancer does not worsen. In the PD-L1 subgroup, the median progression-free survival for those receiving the combination treatment was 7.4 months, versus 4.8 months for those getting the chemotherapy with placebo, according to the FDA's announcement. The trial was funded by Genentech Inc., the maker of Tecentriq.

"This is the first time immunotherapy has worked in such a difficult to treat cancer, and is a huge step forward for these breast cancer patients," lead study author Dr. Peter Schmid of Queen Mary University of London said in an October statement.

Dr. Otis Brawley, Bloomberg Distinguished Professor of oncology and epidemiology at Johns Hopkins University, said the FDA's decision to grant the treatment accelerated approval was "the right thing to do" but cautioned that it's not the end of the story.

"The FDA has approved it based on progression-free survival with the hope that later on ... data will show that the treatment actually makes women live longer," said Brawley, who was not involved in researching the treatment.

This FDA says it grants accelerated approvals to "drugs that treat serious conditions, and that fill an unmet medical need" based on data that suggests, but may not directly measure, a clinical benefit. Drugmakers are still required to confirm that the drug is beneficial through later trials. If that happens, the drug may receive a traditional FDA approval. Otherwise, the agency may decide to pull the drug, as has happened in the past.

In this case, the drugmaker is expected to submit a final report detailing subsequent findings in September 2020, according to the approval letter from the FDA to Genentech.

Tecentriq, the brand name of the immunotherapy drug atezolizumab, was previously approved to treat other specific types of urinary and lung cancers.

Breast cancer patients on the newly approved therapy most commonly reported adverse reactions like hair loss, fatigue, nausea, headaches and decreased appetites, according to the FDA.

Dr. Larry Norton, director of the Evelyn H. Lauder Breast Center at Memorial Sloan Kettering Cancer Center, told CNN in October that scientists are learning "so much and so rapidly about other ways to stimulate the immune system" that he predicts an "explosion of well-designed studies that will push the agenda forward."

Norton, who was not involved in the October study, said "this is just the beginning of using immunotherapy for breast cancer."

Triple-negative breast cancer
About 15% of breast cancers are triple-negative, according to the National Breast Cancer Foundation. The protein PD-L1 may be found in roughly a fifth of those cancers, research has shown.

Triple-negative breast cancer is most likely to affect Hispanic and African-American women and those with a BRCA1 gene mutation. It also tends to appear among women in their 40s and 50s.

"It is particularly tragic that those affected are often young," Queen Mary University's Schmid said. "We have desperately been looking for better treatment options."

When breast cancer cells test negative for estrogen, progesterone or human epidermal growth factor 2 (HER2), it's called a triple-negative breast cancer. Therefore, it does not respond to any of the available hormonal cancer treatments.

It does respond to chemotherapy. However, cancer cells can quickly develop resistance to chemo drugs, allowing them to spread to other parts of the body, reducing survival rates.

How does it work?
Cancers have a way of eluding the body's immune system, which recognizes them as part of the body. That's where Tecentriq comes in: It's an antibody that attaches to the cancer cell and inactivates the PD-L1 protein, which is responsible for telling the immune system, "don't attack me."

Chemotherapy is also needed to "rough up" the exterior of the cancer cell, Schmid explained. That allows the newly revved-up immune system to recognize and attack the invader.

"We are using chemotherapy to tear away the tumor's 'immune-protective cloak,' to expose it," Schmid said, "enabling people's own immune system to get at it."

Norton said in October that "I think the expectation is, this will change the standard of care.

"This is a real advance that is going to allow us to help more people."

Terre Haute
Cloudy
64° wxIcon
Hi: 72° Lo: 60°
Feels Like: 64°
Robinson
Cloudy
65° wxIcon
Hi: 77° Lo: 61°
Feels Like: 65°
Indianapolis
Cloudy
64° wxIcon
Hi: 65° Lo: 58°
Feels Like: 64°
Rockville
Cloudy
64° wxIcon
Hi: 70° Lo: 58°
Feels Like: 64°
Casey
Cloudy
64° wxIcon
Hi: 72° Lo: 60°
Feels Like: 64°
Brazil
Cloudy
64° wxIcon
Hi: 72° Lo: 59°
Feels Like: 64°
Marshall
Cloudy
64° wxIcon
Hi: 71° Lo: 59°
Feels Like: 64°
Scattered Showers and Thundershowers
WTHI Planner
WTHI Temps
WTHI Radar

WTHI Events

 

Illinois Coronavirus Cases

(Widget updates once daily at 7 p.m. CT)

Cases: 1366179

Reported Deaths: 24795
CountyCasesDeaths
Cook54690810144
DuPage907991285
Will75762993
Lake67398990
Kane58533778
Winnebago33359477
Madison30572520
McHenry28675288
St. Clair27899514
Peoria23185317
Champaign20699145
Sangamon18823234
McLean18225181
Tazewell16983291
Rock Island15029318
Kankakee14223210
Kendall1309294
LaSalle12585244
Macon10778200
DeKalb9901119
Vermilion9686132
Adams8474123
Williamson7442130
Whiteside7165172
Boone671774
Ogle612081
Grundy589976
Clinton576390
Coles568996
Knox5569150
Jackson503164
Henry500767
Livingston483185
Stephenson476983
Woodford476177
Effingham472972
Macoupin471583
Marion4471115
Franklin445975
Monroe435793
Jefferson4300120
Lee417453
Randolph413384
Fulton395357
Morgan390282
Logan388959
Montgomery372974
Bureau372782
Christian367973
Fayette317855
Perry317760
Iroquois302766
McDonough286447
Jersey269350
Douglas259035
Saline256454
Lawrence240625
Shelby229937
Union226140
Crawford212126
Bond205524
Cass199525
Jo Daviess181924
Clark180433
Warren180146
Pike179352
Ford179047
Wayne178053
Hancock176131
Carroll175636
Richland175240
Edgar170640
White169826
Washington164425
Moultrie161128
De Witt151725
Mason151645
Piatt150014
Clay148143
Mercer147533
Johnson144515
Greene143933
Massac134640
Wabash134612
Cumberland129019
Menard123712
Jasper115118
Marshall107418
Hamilton83515
Schuyler7607
Brown7106
Pulaski6867
Stark63824
Edwards56912
Henderson52414
Calhoun5182
Putnam4833
Scott4791
Alexander46811
Gallatin4604
Hardin38612
Pope3224
Out of IL111
Unassigned02356

Indiana Coronavirus Cases

(Widget updates once daily at 8 p.m. ET)

Cases: 735462

Reported Deaths: 13480
CountyCasesDeaths
Marion1006161752
Lake54169976
Allen40913680
St. Joseph36301553
Hamilton35807408
Elkhart28815442
Tippecanoe22464219
Vanderburgh22367397
Porter18921310
Johnson18063381
Hendricks17310315
Clark13032192
Madison12754339
Vigo12497249
LaPorte12073215
Monroe11945170
Delaware10750187
Howard9985218
Kosciusko9463117
Hancock8367142
Bartholomew8096156
Warrick7797155
Floyd7686178
Grant7094174
Wayne7069199
Boone6740101
Morgan6606139
Dubois6165117
Marshall6108112
Cass5886105
Dearborn583178
Henry5779105
Noble565084
Jackson503473
Shelby494196
Lawrence4591120
Gibson436892
Harrison436472
DeKalb430485
Clinton428453
Montgomery425789
Whitley397939
Huntington394280
Steuben391057
Miami383768
Knox372890
Jasper372049
Putnam363360
Wabash355280
Adams342655
Ripley340870
Jefferson331881
White316854
Daviess298399
Wells292081
Decatur285992
Fayette281962
Greene280485
Posey272034
LaGrange268870
Scott267454
Clay261147
Washington242132
Randolph242081
Spencer232731
Jennings230949
Starke218954
Fountain213746
Sullivan212242
Owen203056
Jay197630
Fulton196140
Carroll190220
Orange184454
Perry184437
Rush174025
Vermillion170044
Franklin168435
Tipton163345
Parke146716
Pike135334
Blackford135132
Pulaski117345
Newton108834
Brown102641
Crawford101415
Benton99014
Martin89515
Warren82615
Switzerland7948
Union71410
Ohio57111
Unassigned0417